Demand for Diabetic Macular Edema Set for Stupendous Growth in and Post 2020, Buoyed by the Global COVID-19 Pandemic
Date
6/28/2020 4:23:24 AM
(MENAFN- MENAFNAuthors)
FMI’s proven research methodology has helped create another insightful and comprehensive report titled ‘Diabetic Macular Edema Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2027’. In order to infer the market size, historical data, primary responses and public domain data has been thoroughly analysed. Revenue of companies in the global diabetic macular edema market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to forecast the market size over the assessment period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and is extensively scrutinised using advanced tools to garner quantitative and qualitative insights into the global diabetic macular edema market.
A detailed segmentation of the global diabetic macular edema market aids in the understanding of this niche market.
By Therapy Type
- Anti-VEGF
- Ranibizumab (Lucentis)
- Afilbercept (Eylea)
- Corticosteroids
- Fluocinolone Acetonide (Iluvien)
- Dexamethasone (Ozurdex)
- Other Off-label Drugs (Triamcinolone
Acetonide, Bevacizumab and
Pegaptanib)
By Product Form
- Intravitreal Injections
- Intravitreal Implants
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
By Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- MEA
Report Inclusions
This report is divided into four parts. In the introduction, the pertinent market numbers of the global diabetic macular edema market are given along with the CAGR for the forecast period of 2017-2027. The introduction also contains an executive summary of this detailed report through which the report audience can have a cursory glance at this vast market. Also in the introduction, detailed definitions and information on diabetic macular edema are given. In addition, the macroeconomic factors influencing the global diabetic macular edema market are also given in the introduction. Diabetic macular edema market opportunity analysis is given subsequently. In addition, the economic burden of diabetic retinopathy is also stated. The global diabetic macular edema market pipeline analysis is also highlighted here.
In the next section, the regional diabetic macular edema market analysis and forecast is given. The regions are selected as per the market taxonomy. An important sub-section of the report is the market dynamics of the global diabetic macular edema market. The market dynamics section lists the drivers, restraints and trends that are applicable in the global diabetic macular edema market and discusses in detail the factors encouraging the growth of this market as well as the factors hampering the growth of this market. The various trends governing the global diabetic macular edema market – both long term and short term – are also discussed in this part of the report.
The third section of the report contains the competitive landscape of the global diabetic macular edema market. This part constitutes information on the leading companies in the global diabetic macular edema market. The competition landscape gives a dashboard view of the key companies operating in the global diabetic macular edema market along with their important information and broad strategy adopted to stay as leaders in the global diabetic macular edema market. Each of the leading companies is also profiled individually and important information about the company such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis is presented. The last main section of the report contains the global diabetic macular edema market analysis and forecast by therapy type, product form, distribution channel and by region. This section presents important market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global diabetic macular edema market.
Why should you buy this report?
If you are aiming to enter the diabetic macular edema market, this report is a comprehensive guide that will provide crystal clear insights about this vast and lucrative market. All the major treatment types of diabetic macular edema are covered in this report and information is also given on the important regions of the world where this market is likely to boom in the near future, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, then this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
MENAFN2806202002030000ID1100397982
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.